TY - JOUR
T1 - Lymphoscintigraphy in Lymphedema
T2 - Procedure and Interpretation Guideline by the Korean Society of Nuclear Medicine and Korean Society of Lymphedema
AU - The Korean Society of Nuclear Medicine Medical Affairs Committee
AU - Suh, Minseok
AU - Han, Sangwon
AU - Yoo, Min Young
AU - Chae, Sun Young
AU - Choi, Joon Young
N1 - Publisher Copyright:
© The Author(s), under exclusive licence to Korean Society of Nuclear Medicine 2025.
PY - 2025
Y1 - 2025
N2 - The Korean Society of Nuclear Medicine (KSNM) was established in 1961 to promote clinical and technical advancements in nuclear medicine in Republic of Korea, and is composed mainly of nuclear medicine physicians and related scientists. The Korean Society of Lymphedema (KSL) was founded in 2010, gathering physicians, scientists, physical therapists and nurses from various fields to perform basic and clinical research and to study clinical and basic aspects including its pathophysiology, prevention, diagnosis, and treatment related to lymphedema. The KSNM and the KSL have agreed to collaborate on the establishment of a guideline for the implementation and interpretation of lymphoscintigraphy used for the diagnosis and evaluation of lymphedema, and they decided to periodically revise these guidelines to improve the quality of care for lymphedema patients. The purpose of this guideline was to help healthcare providers in taking reasonable actions based on current medical knowledge, available resources, and patient needs while ensuring effective and safe exams, and accurate interpretations in the administration of lymphoscintigraphy for the diagnosis and evaluation of lymphedema.
AB - The Korean Society of Nuclear Medicine (KSNM) was established in 1961 to promote clinical and technical advancements in nuclear medicine in Republic of Korea, and is composed mainly of nuclear medicine physicians and related scientists. The Korean Society of Lymphedema (KSL) was founded in 2010, gathering physicians, scientists, physical therapists and nurses from various fields to perform basic and clinical research and to study clinical and basic aspects including its pathophysiology, prevention, diagnosis, and treatment related to lymphedema. The KSNM and the KSL have agreed to collaborate on the establishment of a guideline for the implementation and interpretation of lymphoscintigraphy used for the diagnosis and evaluation of lymphedema, and they decided to periodically revise these guidelines to improve the quality of care for lymphedema patients. The purpose of this guideline was to help healthcare providers in taking reasonable actions based on current medical knowledge, available resources, and patient needs while ensuring effective and safe exams, and accurate interpretations in the administration of lymphoscintigraphy for the diagnosis and evaluation of lymphedema.
KW - Guideline
KW - Interpretation
KW - Lymphedema
KW - Lymphoscintigraphy
KW - Procedure
UR - https://www.scopus.com/pages/publications/105016620570
U2 - 10.1007/s13139-025-00934-0
DO - 10.1007/s13139-025-00934-0
M3 - Article
AN - SCOPUS:105016620570
SN - 1869-3474
JO - Nuclear Medicine and Molecular Imaging
JF - Nuclear Medicine and Molecular Imaging
ER -